Can you provide the upcoming earnings date for BURNING ROCK BIOTECH LTD-ADR?
BURNING ROCK BIOTECH LTD-ADR (BNR) will report earnings on 2026-06-04.
BURNING ROCK BIOTECH LTD-ADR (BNR) Forecast, Price Target & Analyst Ratings
NASDAQ:BNR • US12233L2060
Current stock price
16.65 USD
-2.41 (-12.64%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BURNING ROCK BIOTECH LTD-ADR (BNR).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $16.65 to mean target of N/A, Based on 5 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
BNR was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about BNR.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed BNR. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-07-14 | CICC | Initiate | Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Jun 4, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 537.435M -4.58% | 515.822M -4.02% | 539.568M 4.60% | 1.142B 111.65% | 1.311B 14.80% | 1.494B 13.96% | 1.69B 13.12% | 1.9B 12.43% | |
| EBITDA YoY % growth | -535.921M 37.42% | -270.232M 49.58% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -669.321M 31.73% | -322.432M 51.83% | -54.845M 82.99% | 44.115M 180.44% | 117.64M 166.67% | 197.47M 67.86% | 261.54M 32.45% | 336.12M 28.52% | |
| Operating Margin | -124.54% | -62.51% | -10.16% | 3.86% | 8.97% | 13.22% | 15.48% | 17.69% | |
| EPS YoY % growth | N/A 22.37% | N/A 95.52% | N/A -277.41% | N/A | N/A | N/A | N/A | N/A |
All data in CNY
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CNY
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
7.02%
Revenue Next 5 Year
9.28%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BURNING ROCK BIOTECH LTD-ADR / BNR Forecast FAQ
What is the consensus rating for BURNING ROCK BIOTECH LTD-ADR (BNR) stock?
The consensus rating for BURNING ROCK BIOTECH LTD-ADR (BNR) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.